Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a relationship exists between the level of
antituberculosis drugs (isoniazid, rifampin, ethambutol, and pyrazinamide) in the blood and
the outcome of HIV-positive patients with tuberculosis. This study also evaluates how these
drugs are absorbed and metabolized in the body.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)